| For: | Rebelos E, Iozzo P, Guzzardi MA, Brunetto MR, Bonino F. Brain-gut-liver interactions across the spectrum of insulin resistance in metabolic fatty liver disease. World J Gastroenterol 2021; 27(30): 4999-5018 [PMID: 34497431 DOI: 10.3748/wjg.v27.i30.4999] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v27/i30/4999.htm |
| Number | Citing Articles |
| 1 |
Boris Mravec, Maria Szantova. The role of the nervous system in liver diseases. Hepatology Research 2024; 54(11) doi: 10.1111/hepr.14125
|
| 2 |
Christy M. Gliniak. Mesenteric adipose tissue: from protective gatekeeper to driver of inflammatory bowel disease. Immunometabolism 2026; 8(2) doi: 10.1097/IN9.0000000000000081
|
| 3 |
So Yeong Cheon, Juhyun Song. Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation. Cell & Bioscience 2022; 12(1) doi: 10.1186/s13578-022-00836-0
|
| 4 |
Johannes R. Hov, Tom H. Karlsen. The microbiota and the gut–liver axis in primary sclerosing cholangitis. Nature Reviews Gastroenterology & Hepatology 2023; 20(3) doi: 10.1038/s41575-022-00690-y
|
| 5 |
Wencheng Li, Youlan Zhou, Qingni Li, Deqiang Wang. The relationship between dyslipidemia and chronic liver disease, with the mediating role of depressive symptoms. Frontiers in Public Health 2025; 13 doi: 10.3389/fpubh.2025.1581622
|
| 6 |
雪 罗. Research Progress of Non-Alcoholic Fatty Liver Disease from the Perspective of Intestinal Flora. Advances in Clinical Medicine 2025; 15(03) doi: 10.12677/acm.2025.153639
|
| 7 |
Yi Zhang, Haixin Ding, Xue Zhao, Yutong Li, Pengling Ge. The immunometabolic network in obesity-associated insulin resistance: a systemic multi-organ and multi-cellular perspective. International Immunopharmacology 2026; 177 doi: 10.1016/j.intimp.2026.116528
|
| 8 |
Eleni Rebelos, Dimitris Kounatidis. Encyclopedia of Endocrine Diseases. 2026; doi: 10.1016/B978-0-443-13825-6.00273-9
|
| 9 |
Miikka-Juhani Honka, Eleni Rebelos, Simona Malaspina, Pirjo Nuutila. Hepatic Positron Emission Tomography: Applications in Metabolism, Haemodynamics and Cancer. Metabolites 2022; 12(4) doi: 10.3390/metabo12040321
|
| 10 |
Xiaozhen Wang, Weiyi Zhao, Xia Li, Lanping Guo, Wenyuan Gao. Structural characterization and hypoglycemic activity of a novel pectic polysaccharide extracted from Atractylodes lancea rhizome. Carbohydrate Polymers 2026; 381 doi: 10.1016/j.carbpol.2026.125096
|
| 11 |
裕梅 范. Research Progress on Rifaximin in Modulating Gut Microbiota for the Treatment of Nonalcoholic Fatty Liver Disease. Advances in Clinical Medicine 2025; 15(01) doi: 10.12677/acm.2025.151161
|
| 12 |
Zhisheng Chen, Mengxin Chen, Ping Zeng, Xiaobo Yang, Qian Li. Association of aspirin with all-cause and cardiocerebrovascular mortality in patients with metabolic associated fatty liver disease. Scandinavian Journal of Gastroenterology 2023; 58(8) doi: 10.1080/00365521.2023.2179864
|
| 13 |
Maurizia R. Brunetto, Antonio Salvati, Giovanni Petralli, Ferruccio Bonino. Nutritional intervention in the management of non-alcoholic fatty liver disease. Best Practice & Research Clinical Gastroenterology 2023; doi: 10.1016/j.bpg.2023.101830
|
| 14 |
Vance L. Albaugh, Yanlin He, Heike Münzberg, Christopher D. Morrison, Sangho Yu, Hans-Rudolf Berthoud. Regulation of body weight: Lessons learned from bariatric surgery. Molecular Metabolism 2023; 68 doi: 10.1016/j.molmet.2022.101517
|
| 15 |
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, Adriano Cressoni Araújo, Ricardo de Alvares Goulart, Marcelo Dib Bechara, Lucas Fornari Laurindo, Nahum Méndez-Sánchez, Sandra Maria Barbalho. Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. International Journal of Molecular Sciences 2024; 25(7) doi: 10.3390/ijms25073694
|
| 16 |
Laura De Rosa, Gabriele Ricco, Maurizia Rossana Brunetto, Ferruccio Bonino, Francesco Faita. Sustainability of General Population Screening for Steatotic Liver Disease: A Proof-of-Concept Study. Healthcare 2025; 13(7) doi: 10.3390/healthcare13070759
|
| 17 |
Taylor J. Kelty, Ryan J. Dashek, W. David Arnold, R. Scott Rector. Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration. Seminars in Liver Disease 2023; 43(01) doi: 10.1055/s-0043-1762585
|
| 18 |
Shi-Lin Cheng, Jun Hao, Hong-Yan Qin. Role of miRNA signalling in the pathogenesis of MASLD. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1756805
|
| 19 |
Jessica Zúñiga-Hernández, Camila Farias, Alejandra Espinosa, Lorena Mercado, Alexies Dagnino-Subiabre, Andrea del Campo, Paola Illesca, Luis A. Videla, Rodrigo Valenzuela. Modulation of Δ5- and Δ6-desaturases in the brain-liver axis. Nutrition 2025; 131 doi: 10.1016/j.nut.2024.112629
|
| 20 |
Antonio Salvati, Lorenzo Bertellotti, Francesco Faita, Daniela Campani, Giovanni Petralli, Simone Cappelli, Ferruccio Bonino, Maurizia Rossana Brunetto. A New Ultrasound Method to Study the Relations Between Ileocecal Valve Incontinence and Inflammation in Metabolic Associated Steatotic Liver Disease. Livers 2026; 6(3) doi: 10.3390/livers6030054
|
| 21 |
Sara Comesaña, Gabriel Pérez-Tierra, Jessica Calo, Cristina Velasco, Marta Conde-Sieira, José L. Soengas. Modulation of peripheral energy metabolism through central leucine administration in rainbow trout (Oncorhynchus mykiss). American Journal of Physiology-Endocrinology and Metabolism 2025; 329(2) doi: 10.1152/ajpendo.00066.2025
|
| 22 |
Yoon-su Ha, Taek-Kyong Kim, Jun Heo, Jintaek Oh, Seung-Kyoon Kim, Jeongkyu Kim, Jeonghyung Lee, Se-Ran Yang, Seonghwan Hwang, Seung-Jin Kim. Rocaglamide-A mitigates LPS-induced hepatic inflammation by modulating JNK/AP-1 signaling cascade and ROS production in hepatocytes. Toxicological Research 2025; 41(1) doi: 10.1007/s43188-024-00263-y
|
| 23 |
Amin Arif, Adil Farooq, Muddasir Hassan Abbasi, Muhammad Babar Khawar, Tasleem Akhtar, Humaira Allay Ali, Mehreen Anjum, Rabia Mehmood, Tayyaba Saleem, Nadeem Sheikh. Effect of heterologous platelet-rich plasma on liver and modulation of glucose metabolism and Wnt signalling pathways in diabetic mice. Molecular Biology Reports 2023; 50(9) doi: 10.1007/s11033-023-08600-4
|
| 24 |
Pengfei Lv, Hongzeng Li, Xiangbo Li, Xueyuying Wang, Jiantong Yu, Yanling Gong. Intestinal perfusion of unacylated ghrelin alleviated metabolically associated fatty liver disease in rats via a central glucagon-like peptide-1 pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024; 326(6) doi: 10.1152/ajpgi.00217.2023
|
| 25 |
M. Yu. Nadinskaia, S. V. Okovityi, V. A. Prikhodko, A. F. Sheptulina, T. A. Deeva, M. V. Maevskaya, M. F. Osipenko. Clinical significance of hyperammonemia in non-alcoholic fatty liver disease. Meditsinskiy sovet = Medical Council 2026; doi: 10.21518/ms2026-204
|